Poster Presentation | Open | Published:
Antibody production by a protease-deficient strain of methylotrophic yeast, Ogataea minuta
Microbial Cell Factoriesvolume 5, Article number: P64 (2006)
At present the expression system of mammalian cells such as CHO has been adopted as the conventional method to produce antibody for pharmaceuticals. However a novel method of producing antibody has been sought after as a substitute for the costly production of antibody by mammalian cells. Therefore, we tried to construct a novel antibody production system by using methylotrophic yeast, O. minuta.
When human antibody genes were introduced in the methylotrophic yeast O. minuta to produce an antibody, the heavy chain of the antibody was partially degraded (see Figure 1, lane 1). Peptide sequencing revealed that degradation occurred in the CH1 region (see Figure 2). In order to inhibit this degradation, the YPS1 gene coding Aspartic protease attached to the plasma membrane, a homologue of Saccharomyces cerevisiae, was cloned from O. minuta, and we constructed the Δyps1 strain. As a result, the Δyps1 strain repressed the partial degradation of the antibody (see Figure 1, lane2).
We constructed a protease-deficient strain and confirmed the secretion of full-length antibody by yeast. Improving the production of antibody should be a subject of further research.
Bourbonnais Y, Larouche C, Tremblay GM: Production of full-length human pre-elafin, an elastase specific inhibitor, from yeast requires the absence of a functional yapsin 1 (Yps1p) endoprotease. Protein Expr Purif. 2000, 20: 485-491. 10.1006/prep.2000.1338.
Wood CR, Boss MA, Kenten JH, Calvert JE, Roberts NA, Emtage JS: The synthesis and in vivo assembly of functional antibodies in yeast. Nature. 1985, 314: 446-449. 10.1038/314446a0.
We thank N.Kawashima, A. Oonishi, Y. Yamamoto, M. Tezuka and K. Sato for their valuable assistance with this research. We are also grateful to Dr. M. Tsukahara for helpful suggestions.